These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35052372)

  • 1. Metformin Affects the Transcriptomic Profile of Chicken Ovarian Cancer Cells.
    Gopalan L; Sebastian A; Praul CA; Albert I; Ramachandran R
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of ascites-derived ovarian tumor cells from spontaneously occurring ovarian tumors of the chicken: evidence for E-cadherin upregulation.
    Tiwari A; Hadley JA; Hendricks GL; Elkin RG; Cooper T; Ramachandran R
    PLoS One; 2013; 8(2):e57582. PubMed ID: 23460878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of adiponectin and its receptors is altered in epithelial ovarian tumors and ascites-derived ovarian cancer cell lines.
    Tiwari A; Ocon-Grove OM; Hadley JA; Giles JR; Johnson PA; Ramachandran R
    Int J Gynecol Cancer; 2015 Mar; 25(3):399-406. PubMed ID: 25700032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin Antagonizes Ovarian Cancer Cells Malignancy Through MSLN Mediated IL-6/STAT3 Signaling.
    Yang X; Huang M; Zhang Q; Chen J; Li J; Han Q; Zhang L; Li J; Liu S; Ma Y; Li L; Yang L; Zou S; Han B
    Cell Transplant; 2021; 30():9636897211027819. PubMed ID: 34238029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
    Zhang F; Chen H; Du J; Wang B; Yang L
    Med Sci Monit; 2018 Sep; 24():6093-6101. PubMed ID: 30171812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy.
    Ferraresi A; Esposito A; Girone C; Vallino L; Salwa A; Ghezzi I; Thongchot S; Vidoni C; Dhanasekaran DN; Isidoro C
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831435
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines.
    Dos Santos Guimarães I; Ladislau-Magescky T; Tessarollo NG; Dos Santos DZ; Gimba ERP; Sternberg C; Silva IV; Rangel LBA
    Pharmacol Rep; 2018 Jun; 70(3):409-417. PubMed ID: 29627688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
    Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
    J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy and protein kinase RNA-like endoplasmic reticulum kinase (PERK)/eukaryotic initiation factor 2 alpha kinase (eIF2α) pathway protect ovarian cancer cells from metformin-induced apoptosis.
    Moon HS; Kim B; Gwak H; Suh DH; Song YS
    Mol Carcinog; 2016 Apr; 55(4):346-56. PubMed ID: 25663310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
    Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
    BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.
    Granata A; Nicoletti R; Tinaglia V; De Cecco L; Pisanu ME; Ricci A; Podo F; Canevari S; Iorio E; Bagnoli M; Mezzanzanica D
    Br J Cancer; 2014 Jan; 110(2):330-40. PubMed ID: 24281000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma
    Shan NL; Minden A; Furmanski P; Bak MJ; Cai L; Wernyj R; Sargsyan D; Cheng D; Wu R; Kuo HD; Li SN; Fang M; Maehr H; Kong AN; Suh N
    Cancer Prev Res (Phila); 2020 Aug; 13(8):673-686. PubMed ID: 32467291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aquaporin 5 expression is altered in ovarian tumors and ascites-derived ovarian tumor cells in the chicken model of ovarian tumor.
    Tiwari A; Hadley JA; Ramachandran R
    J Ovarian Res; 2014 Oct; 7():99. PubMed ID: 25344048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
    Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
    BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Dose of Bisphenol A Modulates Ovarian Cancer Gene Expression Profile and Promotes Epithelial to Mesenchymal Transition Via Canonical Wnt Pathway.
    Hui L; Li H; Lu G; Chen Z; Sun W; Shi Y; Fu Z; Huang B; Zhu X; Lu W; Xia D; Wu Y
    Toxicol Sci; 2018 Aug; 164(2):527-538. PubMed ID: 29718440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer.
    Gwak H; Kim Y; An H; Dhanasekaran DN; Song YS
    Mol Carcinog; 2017 Feb; 56(2):349-358. PubMed ID: 27128966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C; Liu VW; Chan DW; Yao KM; Ngan HY
    Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo.
    Rattan R; Graham RP; Maguire JL; Giri S; Shridhar V
    Neoplasia; 2011 May; 13(5):483-91. PubMed ID: 21532889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
    Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.